Amy L Slogrove1, Kathleen M Powis2, Leigh F Johnson3, John Stover4, Mary Mahy5. 1. Department of Paediatrics and Child Health and Ukwanda Centre for Rural Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Worcester, South Africa. Electronic address: amy@sun.ac.za. 2. Department of Immunology and Infectious Diseases, Harvard T H Chan School of Public Health, Boston, MA, USA; Departments of Internal Medicine and Pediatrics, Massachusetts General Hospital, Boston, MA, USA; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana. 3. Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. 4. Avenir Health, Glastonbury, CT, USA. 5. Strategic Information and Evaluation Department, UNAIDS, Geneva, Switzerland.
Abstract
BACKGROUND: Children who are HIV-exposed uninfected (HEU) have higher morbidity and mortality than children who are HIV-unexposed and uninfected despite safer breastfeeding and improved maternal health with maternal antiretroviral therapy. We present the first global estimates of the population of children who are HEU (aged 0-14 years) and the geographical and temporal trends in HIV high-burden countries between 2000 and 2018. METHODS: The Spectrum AIDS Impact Module developed by Avenir Health, UNAIDS, and partners is used to estimate key HIV epidemic indicators from mathematical models. We used 2019 UNAIDS global estimates of children (aged 0-14 years) who are HEU generated by Spectrum and 2017 UN Population Division estimates of the number of all children in each region or country to estimate the regional or national prevalence of children who were HEU, the regional or national contribution of children who were HEU to the global population of children who were HEU, and the proportion of children who were HEU and exposed to antiretrovirals for six UNAIDS regions and 21 HIV high-burden countries in 2018. We also estimated the percentage change in the global population of children who were HEU between 2000 and 2018. FINDINGS: In 2018, there were an estimated 14·8 million (lower estimate 11·1-upper estimate 18·3) children who were HEU, 13·2 million (9·8-16·3; 90%) of whom resided in sub-Saharan Africa and 760 000 (640 000-970 000; 5%) of whom resided in the Asia and Pacific region. Five countries accounted for 50% of all 14·8 million children who were HEU globally: South Africa (3·5 million [23·8%]), Uganda (1·1 million [7·5%]), Mozambique (1·0 million [6·6%]), Tanzania (910 000 [6·1%]); and Nigeria (880 000 [6·0%]). In five southern African countries, the prevalence of children who were HEU exceeded 15% of the general child population: eSwatini (32·4%), Botswana (27·4%), South Africa (21·6%), Lesotho (21·1%), and Namibia (16·4%). INTERPRETATION: The global population of children who are HEU is substantial, requiring a coordinated strategy to reduce HIV exposure in children and ensure optimal health and wellbeing of children who are HEU and their families. Future research and programmatic funding investments must be aligned with the geographical distribution of children who are HEU. FUNDING: National Institutes of Health, International AIDS Society.
BACKGROUND:Children who are HIV-exposed uninfected (HEU) have higher morbidity and mortality than children who are HIV-unexposed and uninfected despite safer breastfeeding and improved maternal health with maternal antiretroviral therapy. We present the first global estimates of the population of children who are HEU (aged 0-14 years) and the geographical and temporal trends in HIV high-burden countries between 2000 and 2018. METHODS: The Spectrum AIDS Impact Module developed by Avenir Health, UNAIDS, and partners is used to estimate key HIV epidemic indicators from mathematical models. We used 2019 UNAIDS global estimates of children (aged 0-14 years) who are HEU generated by Spectrum and 2017 UN Population Division estimates of the number of all children in each region or country to estimate the regional or national prevalence of children who were HEU, the regional or national contribution of children who were HEU to the global population of children who were HEU, and the proportion of children who were HEU and exposed to antiretrovirals for six UNAIDS regions and 21 HIV high-burden countries in 2018. We also estimated the percentage change in the global population of children who were HEU between 2000 and 2018. FINDINGS: In 2018, there were an estimated 14·8 million (lower estimate 11·1-upper estimate 18·3) children who were HEU, 13·2 million (9·8-16·3; 90%) of whom resided in sub-Saharan Africa and 760 000 (640 000-970 000; 5%) of whom resided in the Asia and Pacific region. Five countries accounted for 50% of all 14·8 million children who were HEU globally: South Africa (3·5 million [23·8%]), Uganda (1·1 million [7·5%]), Mozambique (1·0 million [6·6%]), Tanzania (910 000 [6·1%]); and Nigeria (880 000 [6·0%]). In five southern African countries, the prevalence of children who were HEU exceeded 15% of the general child population: eSwatini (32·4%), Botswana (27·4%), South Africa (21·6%), Lesotho (21·1%), and Namibia (16·4%). INTERPRETATION: The global population of children who are HEU is substantial, requiring a coordinated strategy to reduce HIV exposure in children and ensure optimal health and wellbeing of children who are HEU and their families. Future research and programmatic funding investments must be aligned with the geographical distribution of children who are HEU. FUNDING: National Institutes of Health, International AIDS Society.
Authors: Wendy Yu; Denise L Jacobson; Paige L Williams; Kunjal Patel; Mitchell E Geffner; Russell B Van Dyke; Deborah Kacanek; Linda A DiMeglio; Jennifer Jao Journal: AIDS Date: 2022-03-15 Impact factor: 4.177
Authors: Sonwabile Dzanibe; Katie Lennard; Agano Kiravu; Melanie S S Seabrook; Berenice Alinde; Susan P Holmes; Catherine A Blish; Heather B Jaspan; Clive M Gray Journal: J Immunol Date: 2021-11-24 Impact factor: 5.422
Authors: Sean A Taylor; Shilpee Sharma; Christopher A L Remmel; Beth Holder; Christine E Jones; Arnaud Marchant; Margaret E Ackerman Journal: J Infect Dis Date: 2022-10-17 Impact factor: 7.759
Authors: Nadia M Ikumi; Komala Pillay; Tamara Tilburgs; Thokozile R Malaba; Sonwabile Dzanibe; Elizabeth Ann L Enninga; Rana Chakraborty; Mohammed Lamorde; Landon Myer; Saye Khoo; Heather B Jaspan; Clive M Gray Journal: J Infect Dis Date: 2021-12-08 Impact factor: 7.759
Authors: Aamirah Mussa; Henock B Taddese; Ekaterina Maslova; Gbolahan Ajibola; Joseph Makhema; Roger L Shapiro; Shahin Lockman; Kathleen M Powis Journal: Matern Child Health J Date: 2021-05-05
Authors: Kim Anderson; Emma Kalk; Hlengiwe P Madlala; Dorothy C Nyemba; Nisha Jacob; Amy Slogrove; Mariette Smith; Max Kroon; Michael C Harrison; Brian S Eley; Andrew Boulle; Landon Myer; Mary-Ann Davies Journal: AIDS Date: 2021-05-01 Impact factor: 4.632
Authors: Lisa M Bebell; Mark J Siedner; Joseph Ngonzi; Mylinh H Le; Julian Adong; Adeline A Boatin; Ingrid V Bassett; Drucilla J Roberts Journal: J Acquir Immune Defic Syndr Date: 2020-11-01 Impact factor: 3.771
Authors: Lorraine Sherr; Kathryn J Roberts; Mark Tomlinson; Sarah Skeen; Helen Mebrahtu; Sarah Gordon; Stefani du Toit; Katharina Haag; Lucie D Cluver Journal: AIDS Behav Date: 2021-06-11